Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Håkansson

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Lakartidningen|July 8, 2009
[JUPITER no support of changed guidelines for cardiovascular prevention. Moderate absolute risk reduction and uncertain long term effects]Jan Håkansson
Lakartidningen|September 8, 2009
[The JUPITER study poses more questions than answers]Jan Håkansson
Lakartidningen|November 21, 2007
[Warning signals must be taken seriously!]Jan Håkansson
Lakartidningen|January 14, 2004
["Others are influenced, not me!" Physicians are often not aware how manipulated they are by drug industry]Jan Håkansson
Lakartidningen|November 9, 2002
[Financial interests characterize published reports on coxiber. Whom can we rely on?]Jan Håkansson
Lakartidningen|November 21, 2007
[Glitazones in type 2 diabetes--documented risks, uncertain benefits]Jan Håkansson
Lakartidningen|November 10, 2011
[DSM-5: Psychiatry widens its territory]Jan Håkansson
Lakartidningen|July 27, 2011
[Strengthened support for statin therapy as secondary prevention. Doubtful evidence for more intensive lowering of cholesterol levels]Jan Håkansson
Lakartidningen|January 14, 2003
[Complete and independent scrutiny of coxiber is required]Jan Håkansson
Lakartidningen|September 29, 2012
[Mediterranean diet and statins against cardiovascular disease]Jan Håkansson
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Lakartidningen|July 8, 2009
[JUPITER no support of changed guidelines for cardiovascular prevention. Moderate absolute risk reduction and uncertain long term effects]Jan Håkansson
Lakartidningen|September 8, 2009
[The JUPITER study poses more questions than answers]Jan Håkansson
Lakartidningen|November 21, 2007
[Warning signals must be taken seriously!]Jan Håkansson
Lakartidningen|January 14, 2004
["Others are influenced, not me!" Physicians are often not aware how manipulated they are by drug industry]Jan Håkansson
Lakartidningen|November 9, 2002
[Financial interests characterize published reports on coxiber. Whom can we rely on?]Jan Håkansson
Lakartidningen|November 21, 2007
[Glitazones in type 2 diabetes--documented risks, uncertain benefits]Jan Håkansson
Lakartidningen|November 10, 2011
[DSM-5: Psychiatry widens its territory]Jan Håkansson
Lakartidningen|July 27, 2011
[Strengthened support for statin therapy as secondary prevention. Doubtful evidence for more intensive lowering of cholesterol levels]Jan Håkansson
Lakartidningen|January 14, 2003
[Complete and independent scrutiny of coxiber is required]Jan Håkansson
Lakartidningen|September 29, 2012
[Mediterranean diet and statins against cardiovascular disease]Jan Håkansson
Pageof 4